Another tax season is arriving for cannabis operators, and the old playbook - accept the punishment of Section 280E, minimize where possible, and move on - is no longer the consensus. A growing number of CPAs and operators are filing returns that treat the 1980s anti-drug-trafficker provision as legally inapplicable to cannabis, citing federal health findings that predate any formal rescheduling. The argument is aggressive. It is also, some attorneys and accountants insist, grounded in the actual statutory language.
The Law That Was Never Meant to Tax Small Businesses
Section 280E was written in reaction to a court ruling that allowed a cocaine dealer to deduct business expenses. Congress responded bluntly: no deductions for anyone trafficking in Schedule I or II substances. Drug traffickers were the target. Cannabis retailers, it turned out, were the collateral damage - and the damage is severe.
Because 280E disallows virtually all overhead deductions, licensed cannabis dispensaries are taxed on gross profit rather than net income. Effective tax rates of 60 to 90 percent are not anomalies; they are the documented norm for retail operators, even those barely turning a profit. Cultivators and manufacturers absorb less of the blow because more of their costs qualify as production expenses - cost of goods sold, which 280E does not touch. Dispensaries enjoy no such relief. They pay taxes on money they never actually kept.
That is not a policy side effect. It is the structural outcome of applying a criminal tax penalty to a licensed commercial industry - and it has pushed operators toward insolvency, pushed capital toward vertically integrated multi-state operators with the accounting infrastructure to fight back, and pushed the rest to quietly absorb losses they can barely explain to their own boards.
The Statutory Argument That Is Already in Court
The most consequential shift in this tax season isn't a new IRS ruling or a congressional amendment. It's a reinterpretation of language that has been sitting in the code all along.
Section 280E applies to businesses trafficking in substances that fit the meaning of Schedule I or II - not simply substances that are currently classified there. That distinction, which might look like a drafting technicality, has become the foundation of a serious legal argument. In 2023, the Department of Health and Human Services formally concluded that cannabis does not meet the Schedule I criteria, citing accepted medical use and a lower abuse potential than previously assessed, and recommended reclassification to Schedule III. The Drug Enforcement Administration has not finalized rescheduling, but the HHS finding is a federal government determination - not a lobbying position.
If the substance no longer fits the meaning of Schedule I as defined by its own criteria, the argument runs, then 280E does not apply. Not after rescheduling. Now. That argument is being tested in federal tax court, including proceedings involving New Mexico Top Organics. Trulieve, one of the largest multi-state operators in the country, has reportedly sought a refund in the nine figures based on a related position - a number large enough that the IRS cannot simply look away.
The thing is, none of this requires the IRS to agree. It requires a defensible legal position, documented on the return, supported by disclosure. Form 8275 or 8275-R - the IRS's own mechanism for flagging a reasonable-basis position - allows businesses to file without the deduction reduction while openly stating why. That is not tax evasion. It is a contested legal interpretation, filed transparently, with the supporting rationale on record.
Inventory Accounting as the More Conservative Lever
For operators unwilling to take the full 280E-doesn't-apply position, there is a second strategy that is both less aggressive and still substantially underused: Section 471(c) of the Tax Cuts and Jobs Act.
Before the TCJA, cannabis businesses could attempt to allocate overhead costs into inventory through Section 471A, pulling those costs into cost of goods sold and outside 280E's reach. The approach was narrow and legally fragile. The 2017 tax reform changed that. Under 471(c), businesses with gross revenues below the applicable threshold - currently indexed around $29 million - may use any inventory accounting method that is consistent with their books and records. That opens the door to allocating a substantially larger share of operating costs into inventory, where they can be deducted through COGS rather than blocked by 280E.
The IRS issued guidance in 2022 attempting to restrict how 471(c) could be applied in cannabis contexts. That guidance, however, is regulatory - not statutory. Regulations can interpret law; they cannot override it. Congress wrote 471(c) broadly, and several tax professionals are filing on the basis that the statutory language governs, not the IRS's subsequent narrowing of it. That is a more defensible position than it might sound, and it does not require a client to take a stance on rescheduling at all.
What Operators Actually Need to Do Before Filing
The practical reality for most cannabis operators heading into this tax season is that the risks of the status quo are underappreciated. Filing conservatively - accepting 280E in full - does not make a business safe. It may simply transfer the insolvency risk from an audit to the balance sheet.
Several principles apply regardless of which filing position a business takes. First, bookkeeping quality is not a secondary concern - it is the entire case. Operators who have lost in tax disputes typically did not lose on the legal argument; they lost because their records could not support it. Cannabis-specific accounting requires meticulous cost allocation, particularly for any operator trying to use 471(c) or argue a COGS-expansion position. Sloppy books are not a legal problem; they are an evidentiary one, and the distinction matters enormously in an audit.
Second, business structure determines how tax liability flows. S-corporation treatment passes income directly to the owner's personal return - which can mean a five-figure personal tax bill in a year the business itself barely survived. That is not an argument against S-corp status, but it is an argument for understanding it before filing, not after.
Third, the cannabis industry has a specific problem with professional selection. Many East Coast operators, newer to the licensed market, default to general practice accountants who are unfamiliar with 280E mitigation strategies, 471(c) mechanics, or disclosure procedure. The difference between a CPA who knows this area and one who does not is not marginal - it can be the difference between a viable tax position and an unnecessary six-figure liability.
Audits remain statistically rare among cannabis filers, even those taking aggressive positions. That may not hold as more businesses file outside 280E and the IRS faces pressure to respond. But for now, the legal frontier is moving faster than enforcement is. Operators who understand the argument, document it properly, and work with accountants who know the code - not just the conventions - are in a better position than most of the industry realizes.
